Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Antibiotic Selection00:57

Antibiotic Selection

59.3K
Overview
59.3K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.1K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.1K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

736
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
736
Antimicrobial Proteins01:23

Antimicrobial Proteins

12.8K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.8K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

441
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
441

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Cannabinoid (CB) 1 receptor antagonists block fentanyl conditioned place preference but not fentanyl antinociception.

Drug and alcohol dependence·2026
Same author

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
Same author

METTL3 regulates exocytosis independently of m<sup>6</sup>A.

Science advances·2026
Same author

Mitochondrial dysfunction in muscle cells induced by snoring vibrations.

Mitochondrion·2026
Same author

Identification of drug repurposing candidates for the treatment of polycystic kidney disease.

British journal of pharmacology·2026
Same author

A deformylase inhibitor expands therapeutic options for Lyme disease.

Research square·2026

関連する実験動画

Updated: Jan 3, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.6K

新しい 抗生物質 が グラム ネガティブ の 病原体 を 選択 的 に 殺す

Yu Imai1, Kirsten J Meyer1, Akira Iinishi1

  • 1Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.

Nature
|November 21, 2019
PubMed
まとめ

薬剤耐性グラム陰性病原体に対して有効な新型抗生物質であるドロバクチンを発見しました この化合物は 細菌の共生体から得られ 重要な外膜タンパク質を標的とし 治療の新たな希望を示しています

さらに関連する動画

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

11.2K
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

12.9K

関連する実験動画

Last Updated: Jan 3, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.6K
Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

11.2K
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

12.9K

科学分野:

  • 微生物学
  • 薬物の発見
  • 生物化学

背景:

  • 薬剤耐性のグラム陰性病原体の増加は 新種の抗生物質を必要とします
  • グラム陰性細菌は,抗生物質の浸透を阻害する制限的な浸透性バリアを持っています.
  • グラム陰性細菌に対する新しい抗生物質の開発は1960年代から停滞している.

研究 の 目的:

  • 薬剤耐性グラム陰性病原体に対して有効な新種の抗生物質を特定する.
  • 新しい抗菌剤の源として バクテリアの共生体を探る
  • ダロバクチンという 新しく発見された抗生物質の特徴です

主な方法:

  • 抗生物質活性に対するPhotorhabdusバクテリア分離物のスクリーニング
  • ダロバクチンの遺伝的基礎と生物合成の調査
  • ドロバクチンの有効性を in vitro および動物感染モデルで評価する.
  • 抵抗性のメカニズムを分析して 抵抗性の変異体を特定する

主要な成果:

  • ダロバクチンの発見 リボソームで合成された新種の抗生物質
  • ダロバクチンは,グラム陰性病原体に対してin vitroおよびin vivoで強力な活性を示しています.
  • ダロバクチンは,翻訳後に形成された2つの融合リングを持つユニークな構造を持っています.
  • ダロバクチンに対する耐性は,重要な外膜タンパク質トランスロケータであるBamaの変異から生じる.

結論:

  • バクテリアの動物共生体は 有望な抗生物質候補を備えています
  • ダロバクチンは,グラム陰性細菌感染症の治療に有効な治療薬である.
  • BamAをターゲットにすることは 難しい病原体に対する新しい抗生物質の開発に 有効な戦略です